Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
about
The Interactions of Obesity, Inflammation and Insulin Resistance in Breast CancerAdipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokinesRegulatory dendritic cells: there is more than just immune activationRelationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk preventionMethylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin StudyAssociation of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitusCirculating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo.Effect of diet or diet plus physical activity versus usual care on inflammatory markers in patients with newly diagnosed type 2 diabetes: the Early ACTivity in Diabetes (ACTID) randomized, controlled trial.The gp130 receptor cytokine family: regulators of adipocyte development and function.Human resistin: found in translation from mouse to manTetrapleura tetraptera spice attenuates high-carbohydrate, high-fat diet-induced obese and type 2 diabetic rats with metabolic syndrome featuresCentral obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.Assessing the evidence: Exploring the effects of exercise on diabetic microcirculation.Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Increased Gustatory Response Score in Obesity and Association Levels with IL-6 and Leptin.Triiodothyronine modulates the expression of leptin and adiponectin in 3T3-L1 adipocytes.The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK.Lipotoxicity of palmitic Acid on neural progenitor cells and hippocampal neurogenesis.Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese portuguese patients with type 2 diabetes.Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.Effects of exercise on inflammation markers in type 2 diabetic subjects.Oncostatin m modulation of lipid storage.Postnatal overfeeding leads to obesity and exacerbated febrile responses to lipopolysaccharide throughout life.Incidence and correlated factors of beta cell failure in a 4-year follow-up of patients with type 2 diabetes: a longitudinal analysis of the BETADECLINE study.Adipokine Profile in Patients with Type 2 Diabetes Depends on Degree of Obesity.Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial.The influence of level of spinal cord injury on adipose tissue and its relationship to inflammatory adipokines and cardiometabolic profiles.Neurogenic obesity and systemic inflammation following spinal cord injury: a review.Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease.Relation between C-reactive protein and impaired fasting glucose in obese subjects.Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome.IL-6, TNF-α, and IL-10 levels/polymorphisms and their association with type 2 diabetes mellitus and obesity in Brazilian individuals.
P2860
Q26777775-E0882C9C-57B0-439D-AD69-241E9AB7876AQ27001148-8C2623AB-5809-4E16-B69F-EAA3F598D909Q28388235-D2572DF7-CB8B-43E3-A3F9-1DBBF881C3C1Q33627732-54F4228F-8D93-4433-A476-3D801651373EQ33632915-F2D80D1A-EB0A-4094-9811-AFBC8B4FE8E7Q34256560-D51A9AC0-AC85-4955-9333-A77E23CBD1B2Q34281793-46E10C4B-1FC5-4596-BC98-9256C116318CQ34827533-61D687E9-0D54-40AB-95E4-2A888A0F05B7Q35021892-EA2F2967-DB52-4CBF-8388-05B3D6F10C14Q35059389-66245211-1B86-4971-8CBD-B66435463581Q35087560-26E60722-4891-44FA-AF05-A038CB3B458AQ35663252-CA7DE448-96A4-4106-9386-485C8A6A48C8Q35829203-73905C69-CD6D-4BD4-8BFE-A43FDBAFA0DDQ36170520-A247D03D-5B8D-4AFE-B677-A133D8A7C586Q36502629-8BAFC374-D2DC-400C-B763-F3480E00AF30Q37054133-9A158840-FFBE-4D43-AD6B-812DDECB6E76Q37098564-A5E3EB73-F3DD-4F5A-B0AF-88AB7B30C58CQ37309992-9289FC44-C195-4082-AF8A-EE647C63E5C1Q37326225-EB5C567D-CF1C-4D3C-BFDD-6C1C70841510Q37515305-B8219651-B39F-4B50-838A-CD9C8E8E6B20Q37554810-48332579-D15B-408C-9F61-C0D775B629A1Q37856870-7F98CB8C-FA2F-4C3D-ADD4-C38523D4CC08Q38358416-967C9DE5-D58A-4ECF-9C56-AA6F2C8EEA3EQ40302454-28AAE984-6BF2-4E18-9FFE-7DBD34BFB26AQ40747617-8055A5AD-777D-4555-A7EB-1974DF468244Q42616529-AA28DCDB-EDE8-4360-B656-D5EBADFF6254Q45342050-46ACB46F-389A-4509-A824-0F9C3961E82BQ48010138-BB155DAA-B270-48C6-9C1F-8548F57D4A7BQ48321642-4B78AD49-EED2-42DB-97E6-57E9F6B24838Q51268571-4EF62DB5-82DC-4E51-A8B4-1CEEC1510612Q51355400-CF1D8FF4-A96A-42F5-9A0A-FC07C5A5409CQ51361015-CE3E433D-9804-424B-A987-DE840C7ABF38Q54127558-1C31DAD5-58D0-4E6A-8A1F-78823BA37C02
P2860
Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Plasma adipokine and inflammat ...... ese, type 2 diabetes patients.
@ast
Plasma adipokine and inflammat ...... ese, type 2 diabetes patients.
@en
type
label
Plasma adipokine and inflammat ...... ese, type 2 diabetes patients.
@ast
Plasma adipokine and inflammat ...... ese, type 2 diabetes patients.
@en
prefLabel
Plasma adipokine and inflammat ...... ese, type 2 diabetes patients.
@ast
Plasma adipokine and inflammat ...... ese, type 2 diabetes patients.
@en
P2093
P2860
P1476
Plasma adipokine and inflammat ...... ese, type 2 diabetes patients.
@en
P2093
Annelies Mullens
Dominique Hansen
Luc J C van Loon
Luk Corluy
Milou Beelen
Paul Dendale
Richard A M Jonkers
Romain Meeusen
P2860
P2888
P304
P356
10.1007/S00421-010-1362-5
P577
2010-02-04T00:00:00Z